Slide 1HCV INFECTION AND MANAGEMENT IN ADVANCED LIVER DISEASE Kimberly Brown, M.D. Chief, Division of Gastroenterology and Hepatology Henry Ford Hospital Slide 2 Disclosures…

Slide 1Alfredo ALBERTI Slide 2 How to predict outcome in hepatitis C patients Alfredo Alberti Department of Clinical and Experimental Medicine Venetian Institute of Molecular…

Slide 1Hosny Salama Hepatitis-2015 Orlando, USA July 20 - 22 2015 Slide 2 Effect of Sofosbuvir, Brand drug ( Sofaldi ) versus generic ( MPIviropack ) in treating chronic…

Slide 1 CADTH SYMPOSIUM : HCV: NATURAL HISTORY AND THERAPEUTICS Alnoor Ramji Gastroenterology & Hepatology Clinical Associate Professor Division of Gastroenterology University…

Slide 1 IMPACT OF ORGAN AND NON-ORGAN-SPECIFIC AUTOANTIBODIES ON THE TREATMENT OUTCOME OF PATIENTS WITH HEPATITIS D VIRUS INFECTION 1 Department of Gastroenterology, Hepatology…

Slide 1 Cancers of the liver and pancreas Slide 2 Describe hepatocellular and cholangiocarcinoma. Understand the frequency of metastatic disease to the liver. Recognize the…

Slide 1 BORDERNETwork Training on Hepatitis C Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A. www.bordernet.eu www.aidshilfe-potsdam.de Slide 2 This presentation arises…

Slide 1 1 Managing Side Effects of Medications for HCV Nursing Inservice Rajwant Minhas, FH Resident HIV/AIDS Rotation May 2012 Slide 2 2 Objectives Be aware of common side…

Slide 1 Clinical Experience: Difficulties in Clinical Trial Design for Therapeutic Products to Treat Chronic HCV Infection John M. Vierling, M.D., F.A.C.P. Professor of Medicine…

Slide 1 HCV: Stemming the Tidal Wave R. Logan Faust, MD, FACG California Association for Nurse Practitioners Symposium, October 2014 Slide 2 Slide 3 Slide 4 Timeline-Hepatitis…